← SynDRA
BMS-863233
SynDRA canonical compound SYN1206003 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CDC7 | PIM1 |
|---|
| Mechanism of action | CDC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CDC7 INHIBITOR
- Cell division cycle 7-related protein kinase inhibitor
- PIM1 INHIBITOR
- CDC inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- XL413
- XL 413
- UNII-8QK62S7492
- BMS863233
- CHEBI:189662
- RefChem:120752
- CDC7 Kinase Inhibitor BMS-863233
- Cell Division Cycle 7 Homolog Kinase Inhibitor BMS-863233
- 8QK62S7492
- MFCD28137679
- 0SX
- GTPL8113
- orb1695994
- SCHEMBL1853714
- SCHEMBL31060508
- UWB55838
- BDBM50383714
- NSC800971
- BMS 863233 [WHO-DD]
- AKOS030526282
- CS-1956
- NSC-800971
- NCGC00378617-09
- NCGC00378617-10
- NCGC00390286-01
- AC-35325
- HY-15260
- TS-08761
- BMS-863233 (XL-413)
- NS00072995
- BRD-K12511835-003-01-2
- BRD-K12511835-003-02-0
- BMS 863233
- 8-chloro-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one
- XL-413
- HY-15260A
- orb1738141
- AKOS025147371
- BMS-863233 hydrochloride
Look up BMS-863233 in the interactive SynDRA portal →